The National Foundation for Infectious Diseases (NFID) convened a multidisciplinary expert roundtable in January 2021 to share research, insights, and best practices for improving and harmonizing communication to the public about the evolving COVID-19 pandemic and the importance of following evidence-based public health prevention measures. Based on the roundtable discussion, NFID developed a a report, COVID-19 Communications: Promoting Prevention Measures and Vaccine Confidence, to provide a framework for developing effective communications.
We all have a role to play in educating the public about COVID-19 prevention measures. But as science continues to evolve and recommendations shift, there is potential for confusion and frustration.
Related Resources
What Is A Monoclonal Antibody?
Animated video on monoclonal antibodies–what they are, how they work, and their real-world applications for COVID-19 and RSV
Maria’s Story (COVID-19)
Maria was a healthy, active 41-year-old who contracted COVID-19 before vaccines were available, and is now a severe COVID-19/ECMO survivor and a vaccine advocate
Monoclonal Antibodies Fact Sheet (Spanish)
Spanish fact sheet provides information on monoclonal antibodies (mAbs) and the differences between vaccines and mAbs